Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0H3ID
|
||||
Former ID |
DCL000925
|
||||
Drug Name |
Pfizer 10
|
||||
Indication | Female sexual dysfunction [ICD9: 302.7; ICD10:F52] | Phase 1 | [1] | ||
Company |
Pfizer
|
||||
Target and Pathway | |||||
Target(s) | D(3) dopamine receptor | Target Info | Agonist | [1] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
Dopaminergic synapse | |||||
Reactome | Dopamine receptors | ||||
G alpha (i) signalling events | |||||
WikiPathways | Monoamine GPCRs | ||||
GPCRs, Class A Rhodopsin-like | |||||
GPCR ligand binding | |||||
GPCR downstream signaling | |||||
Nicotine Activity on Dopaminergic Neurons | |||||
GPCRs, Other | |||||
References | |||||
REF 1 | Designing drugs for the treatment of female sexual dysfunction. Drug Discov Today. 2007 Sep;12(17-18):757-66. Epub 2007 Aug 27. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.